台股 » 個股 » 明達醫 » 籌碼相關 » 券商分點績效

明達醫

(6527)
  • 股價
    81.5
  • 漲跌
    ▲1.0
  • 漲幅
    +1.24%
  • 成交量
    12
  • 產業
    上櫃 生技醫療類股
  • 37人加入追蹤

    立即追蹤

  • 本地時間:13:30

     
明達醫 (6527)籌碼相關-券商分點績效/獲利分析
券商分點績效/獲利分析

透過統計各券商分點在長期買賣某個股的操作績效,來找出真正獲利的贏家所在券商分點,進而追蹤此贏家所操作的股票與軌跡。

«前一日     2024/04/11 ~ 2024/04/25     後一日»

券商獲利排行 - 2024/04/11 ~ 2024/04/25

券商分點績效總損益(仟)己實現(仟)未實現(仟)買賣超買張賣張均價均買均賣現價
  4.31%534.613.2521.41491591078.17879.381.5
  3.92%64.3-0.464.71921278.178.177.981.5
  1.95%51.8051.8-3203283.1083.181.5
  3.70%46.51.5451416178.678.58081.5
  4.49%35035101007878081.5
  3.66%24159-53881.978.383.381.5
  5.57%21.5021.555077.277.2081.5
  2.00%18.88.410.4312978.4787981.5
  3.41%15.90.415.546277.777.677.881.5
  2.81%15.710.65.127579.878.98181.5
  2.98%13.92.211.736377.877.678.381.5
  3.43%13.5013.555078.878.8081.5
  3.70%11.50.211.334177.877.777.981.5
  1.53%11.4011.4-90982.8082.881.5
  1.03%10.6-717.6913479.179.577.881.5
  2.46%9.89.8005579.678.680.681.5
  5.84%9092207777081.5
  5.57%8.608.622077.277.2081.5
  3.17%7.84.53.2-21381.878.683.181.5
  4.55%7.107.12207878081.5
  0.33%6.906.92626081.281.2081.5
  2.91%6.906.923079.179.277.481.5
  4.34%6.806.822078.178.1081.5
  4.04%6.64.81.8-11281.778.583.381.5
  4.15%6.506.522078.378.3081.5
  3.77%6.24.12.2-11282.379.683.781.5
  1.50%60645180808081.5
  2.36%5.905.9-30383.5083.581.5
  1.56%5.2-0.25.4-31483.383.583.381.5
  1.26%5.205.2-50582.5082.581.5
  3.23%5.105.12207979081.5
  2.09%50533079.879.8081.5
  2.08%4.9-0.95.823178.478.677.781.5
  6.02%4.84.8001180.377.882.681.5
  1.96%4.704.733079.979.9081.5
  1.19%4.613.715477.977.878.181.5
  2.90%4.604.622079.279.2081.5
  5.84%4.504.51107777081.5
  5.71%4.404.411077.177.1081.5
  5.57%4.304.311077.277.2081.5
  5.29%4.34.3001181.279.183.481.5
  2.45%4.104.1-20283.6083.681.5
  5.30%4.104.111077.477.4081.5
  5.03%4.14.1001181.679.583.681.5
  1.71%4.104.12308080.177.181.5
  1.71%4.104.133080.180.1081.5
  5.16%40411077.577.5081.5
  5.03%3.903.911077.677.6081.5
  5.02%3.903.911077.677.6081.5
  4.66%3.83.8001181.579.683.481.5

券商虧損排行 - 2024/04/11 ~ 2024/04/25

券商分點績效總損益(仟)己實現(仟)未實現(仟)買賣超買張賣張均價均買均賣現價
  -4.80%-306.6-10.5-296.1-8028277.983.177.881.5
  -3.86%-37.2-20.1-17.1-651280.383.179.181.5
  -5.82%-35.90-35.9-8087707781.5
  -5.57%-34.40-34.4-80877.2077.281.5
  -3.52%-33.30-33.3-1201278.7078.781.5
  -4.53%-31.80-31.8-9097883.47881.5
  -6.80%-27.1-27.1005579.782.47781.5
  -1.02%-23-13.2-9.8-6222880.180.579.981.5
  -5.84%-22.50-22.5-5057707781.5
  -5.57%-21.9-6.3-15.6-41578.783.977.681.5
  -2.89%-20.7-2.5-18.2-81979.581.779.281.5
  -5.16%-200-20-50577.5077.581.5
  -1.43%-19.7-11.8-7.9-6101780.881.580.481.5
  -3.56%-14.1-14.1005579.58178.281.5
  -4.39%-13.70-13.7-40478.1078.181.5
  -3.32%-13.1-1.9-11.2-4157980.678.781.5
  -3.15%-12.6-3.7-8.9-41579.982.979.381.5
  -3.15%-12.40-12.4-5057907981.5
  -4.72%-11.3-7.9-3.4-12379.782.178.181.5
  -2.30%-11.2-10.1-1.12648182.179.581.5
  -4.76%-11.10-11.1-30377.8077.881.5
  -3.30%-10.40-10.4-40478.9078.981.5
  -4.04%-9.50-9.5-30378.3078.381.5
  -3.95%-9.30-9.3-30378.4078.481.5
  -1.42%-9.10-9.1-80880.4080.481.5
  -5.84%-90-9-2027707781.5
  -5.71%-8.80-8.8-20277.1077.181.5
  -2.67%-8.4-0.1-8.3-31478.778.878.781.5
  -5.36%-8.4-3.9-4.5-11278.380.97781.5
  -5.43%-8.40-8.4-20277.3077.381.5
  -5.43%-8.40-8.4-20277.3077.381.5
  -3.46%-8.4-6.6-1.8-1238183.179.781.5
  -2.61%-8.3-1.4-6.9-21479.580.679.281.5
  -5.23%-8.10-8.1-20277.5077.581.5
  -3.23%-7.60-7.6-3037907981.5
  -3.23%-7.60-7.6-3037907981.5
  -4.83%-7.50-7.5-20277.777.377.781.5
  -4.76%-7.40-7.4-20277.8077.881.5
  -4.35%-6.80-6.8-20278.1078.181.5
  -4.33%-6.80-6.8-10278.583.378.181.5
  -1.62%-6.70-6.755082.882.8081.5
  -4.13%-6.50-6.5-20278.3078.381.5
  -3.96%-6.20-6.2-20278.57978.481.5
  -7.58%-6.1-6.1001180.583.577.481.5
  -2.51%-6.1-4.9-1.223180.982.177.281.5
  -3.82%-60-6-20278.5078.581.5
  -6.84%-5.5-5.5001180.583.277.781.5
  -2.20%-5.4-5.4003381.882.780.981.5
  -2.26%-5.40-5.4-30379.7079.781.5
  -1.36%-5.41.1-6.5-32579.278.879.381.5
〈台股盤前要聞〉板卡廠啖AI財淡季有撐、明達醫私募案年底定案 今日必看財經新聞Anue鉅亨-2023/10/02
明達醫八德廠拚明年動工 私募案目標年底定案Anue鉅亨-2023/10/01
明達醫能見度達2季 明年再推眼科新品添成長動能Anue鉅亨-2023/09/26
明達醫 相關文章
明達醫 相關影音